Skip to playerSkip to main contentSkip to footer
  • 5/28/2025
Elon Musk’s Neuralink has raised $600 million in new funding, boosting its valuation from $3.5 billion to $9 billion, according to Semafor. The announcement follows successful chip implantations in three patients, including a non-verbal man with ALS who demonstrated communication abilities via the device. The funding boost supports Neuralink’s ongoing progress in developing brain-computer interfaces, including recent chip implants in patients with severe communication impairments. The latest funding round strengthens its finances and reflects growing investor confidence in its potential to transform healthcare and communication. Musk announced at the Qatar Economic Forum that Neuralink plans to begin clinical trials by 2026 for its Blindsight implant, which aims to restore vision in completely blind individuals.

Category

🗞
News
Transcript
00:00It's Benzinga bringing Wall Street to Main Street.
00:02Elon Musk's Neuralink has raised $600 million in new funding,
00:05boosting its valuation from $3.5 billion to $9 billion, according to Semaphore.
00:10The announcement found successful chip implantations in three patients,
00:13including a nonverbal man with ALS who demonstrated communication abilities via the device.
00:18Funding boosts supports Neuralink's ongoing progress in developing brain-computer interfaces,
00:23including recent chip implants in patients with severe communication impairments.
00:27The latest funding round strengthens its finances and reflects growing investor confidence
00:32in its potential to transform health care and communication.
00:35Musk announced at the Cutter Economic Forum that Neuralink plans to begin clinical trials by 2026
00:41for its Blind Sight and Plan, which aims to restore vision in completely blind individuals.
00:46For all things money, visit Benzinga.com slash GSTV.

Recommended

1:03
Up next